To validate the role of FADS2 in adrenocortical steroidogenesis in obesity, we treated HFD mice with the FADS2 inhibitor SC-26196 and assessed corticosteroid production. This evidence concerns the gene FADS2 and obesity due to melanocortin 4 receptor deficiency.